DE69933200D1 - Kombinierte impfstoffzusammensetzungen - Google Patents
Kombinierte impfstoffzusammensetzungenInfo
- Publication number
- DE69933200D1 DE69933200D1 DE69933200T DE69933200T DE69933200D1 DE 69933200 D1 DE69933200 D1 DE 69933200D1 DE 69933200 T DE69933200 T DE 69933200T DE 69933200 T DE69933200 T DE 69933200T DE 69933200 D1 DE69933200 D1 DE 69933200D1
- Authority
- DE
- Germany
- Prior art keywords
- vaccine compositions
- combined vaccine
- combined
- compositions
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9805105.5A GB9805105D0 (en) | 1998-03-09 | 1998-03-09 | Novel composition |
GB9805105 | 1998-03-09 | ||
GBGB9813561.9A GB9813561D0 (en) | 1998-06-23 | 1998-06-23 | Novel composition |
GB9813561 | 1998-06-23 | ||
PCT/EP1999/001406 WO1999045957A2 (en) | 1998-03-09 | 1999-03-04 | Combined vaccine compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69933200D1 true DE69933200D1 (de) | 2006-10-26 |
DE69933200T2 DE69933200T2 (de) | 2007-02-22 |
Family
ID=26313263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69933200T Expired - Lifetime DE69933200T2 (de) | 1998-03-09 | 1999-03-04 | Kombinierte impfstoffzusammensetzungen |
Country Status (22)
Country | Link |
---|---|
US (2) | US6451320B1 (de) |
EP (1) | EP1064025B1 (de) |
JP (1) | JP4510283B2 (de) |
KR (1) | KR20010041629A (de) |
CN (1) | CN1299288A (de) |
AR (1) | AR014684A1 (de) |
AT (1) | ATE339223T1 (de) |
AU (1) | AU750720B2 (de) |
BR (1) | BR9908599A (de) |
CA (1) | CA2324289C (de) |
CO (1) | CO4960659A1 (de) |
DE (1) | DE69933200T2 (de) |
ES (1) | ES2273482T3 (de) |
HU (1) | HUP0101047A3 (de) |
IL (1) | IL137998A0 (de) |
MY (1) | MY135965A (de) |
NO (1) | NO20004487L (de) |
NZ (1) | NZ506602A (de) |
PL (1) | PL343429A1 (de) |
TR (1) | TR200002608T2 (de) |
TW (1) | TW580393B (de) |
WO (1) | WO1999045957A2 (de) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849719A (en) * | 1993-08-26 | 1998-12-15 | The Regents Of The University Of California | Method for treating allergic lung disease |
US20030078223A1 (en) * | 1996-01-30 | 2003-04-24 | Eyal Raz | Compositions and methods for modulating an immune response |
PL201482B1 (pl) | 1998-10-16 | 2009-04-30 | Smithkline Beecham Biolog | Sposoby wytwarzania kompozycji szczepionki oraz kompozycja szczepionki |
CN1391482A (zh) * | 1999-01-12 | 2003-01-15 | 史密丝克莱恩比彻姆生物有限公司 | 新型治疗方法 |
US20050002958A1 (en) * | 1999-06-29 | 2005-01-06 | Smithkline Beecham Biologicals Sa | Vaccines |
GB9921147D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
AU2003236490B2 (en) * | 1999-09-07 | 2004-08-19 | Smithkline Beecham Biologicals S.A. | Novel composition |
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
US7811574B2 (en) | 2000-02-23 | 2010-10-12 | Glaxosmithkline Biologicals S.A. | Tumour-specific animal proteins |
CA2400842C (en) * | 2000-02-23 | 2013-01-15 | Smithkline Beecham Biologicals S.A. | Novel compounds |
UA79735C2 (uk) * | 2000-08-10 | 2007-07-25 | Глаксосмітклайн Байолоджікалз С.А. | Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах |
GB0019728D0 (en) * | 2000-08-10 | 2000-09-27 | Smithkline Beecham Biolog | Novel treatment |
KR20050048539A (ko) * | 2001-10-06 | 2005-05-24 | 메리얼엘엘씨 | CpG 제제 및 관련된 방법 |
GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206359D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0210682D0 (en) * | 2002-05-09 | 2002-06-19 | Glaxosmithkline Biolog Sa | Novel use |
KR100525321B1 (ko) * | 2002-12-13 | 2005-11-02 | 안웅식 | 파필로마바이러스 항원 단백질 및CpG-올리고데옥시뉴클레오타이드를 포함하는파필로마바이러스 유발 질환의 예방 또는 치료용 약제학적조성물 |
US7858098B2 (en) | 2002-12-20 | 2010-12-28 | Glaxosmithkline Biologicals, S.A. | Vaccine |
CN1513555A (zh) * | 2003-07-31 | 2004-07-21 | 长春生物制品研究所 | 甲-乙型肝炎联合疫苗及其冻干制剂 |
US7758866B2 (en) | 2004-06-16 | 2010-07-20 | Glaxosmithkline Biologicals, S.A. | Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52 |
EP1863529A1 (de) * | 2005-03-23 | 2007-12-12 | GlaxoSmithKline Biologicals S.A. | Neue zusammensetzung |
US8865185B2 (en) * | 2006-09-08 | 2014-10-21 | The Trustees Of The University Of Pennsylvania | Methods of use for HSV-1 and HSV-2 vaccines |
JP5639361B2 (ja) * | 2006-09-08 | 2014-12-10 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Hsv−1及びhsv−2ワクチン並びにその使用方法 |
US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
HUE037808T2 (hu) | 2006-09-26 | 2018-09-28 | Infectious Disease Res Inst | Szintetikus adalékanyagot tartalmazó vakcina kompozíció |
US8057804B2 (en) * | 2006-12-28 | 2011-11-15 | The Trustees Of The University Of Pennsylvania | Herpes simplex virus combined subunit vaccines and methods of use thereof |
US10478490B2 (en) | 2006-12-28 | 2019-11-19 | The Trustees Of The University Of Pennsylvania | Herpes simplex virus combined subunit vaccines and methods of use thereof |
WO2008085486A1 (en) * | 2006-12-28 | 2008-07-17 | The Trustees Of The University Of Pennsylvania | Herpes simplex virus combined subunit vaccines and methods of use thereof |
ES2565846T3 (es) * | 2008-05-26 | 2016-04-07 | Cadila Healthcare Limited | Vacuna combinada contra el sarampión-papiloma humano |
WO2010135749A1 (en) | 2009-05-22 | 2010-11-25 | Genocea Biosciences Inc. | Herpes simplex virus type2: compositions and methods for eliciting an immune response |
KR20120014054A (ko) | 2009-05-27 | 2012-02-15 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | Casb7439 작제물 |
BRPI1011072B1 (pt) | 2009-06-05 | 2021-09-28 | Infectious Disease Research Institute | Composto de gla, composições de vacina e farmacêutica compreendendo dito composto, bem como uso dos mesmos para estimular, induzir ou acentuar uma resposta imune em um indivíduo |
EP2544693B1 (de) * | 2010-03-09 | 2017-09-13 | Biomedical Research Models, Inc. | Neuer schleimhautimpfungsansatz für den herpes-simplex-virus vom typ 2 |
EP3388081A1 (de) * | 2010-05-26 | 2018-10-17 | Selecta Biosciences, Inc. | Multivalente synthetische nanoträger-impfstoffe |
EP2643014A4 (de) | 2010-11-24 | 2015-11-11 | Genocea Biosciences Inc | Impfstoffe gegen den herpes-simplex-virus vom typ 2: zusammensetzungen und verfahren zur auslösung einer immunreaktion |
JP6054942B2 (ja) | 2011-04-08 | 2016-12-27 | イミューン デザイン コーポレイション | 免疫原性組成物、ならびに体液性および細胞性免疫応答を誘発するための該組成物の使用方法 |
CN102210858B (zh) * | 2011-05-18 | 2013-05-08 | 北京科兴生物制品有限公司 | 一种肠道病毒71型与甲型肝炎联合疫苗 |
CA2843854A1 (en) * | 2011-07-01 | 2013-01-10 | The Regents Of The University Of California | Herpes virus vaccine and methods of use |
WO2013078299A1 (en) | 2011-11-23 | 2013-05-30 | Genocea Biosciences, Inc. | Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
RS58868B1 (sr) | 2012-02-07 | 2019-08-30 | Infectious Disease Res Inst | Poboljšane adjuvansne formulacije koje sadrže agoniste tlr4 i postupci upotrebe istih |
KR102136433B1 (ko) | 2012-05-16 | 2020-07-22 | 이뮨 디자인 코포레이션 | Hsv-2 백신 |
WO2014107731A1 (en) | 2013-01-07 | 2014-07-10 | Biomedical Research Models, Inc. | Therapeutic vaccines for treating herpes simplex virus type 2 infections |
EP3711768A1 (de) | 2013-04-18 | 2020-09-23 | Immune Design Corp. | Gla-monotherapie zur verwendung in der krebsbehandlung |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
JP6741580B2 (ja) | 2013-12-31 | 2020-08-19 | インフェクシャス ディズィーズ リサーチ インスティチュート | 単一バイアルのワクチン製剤 |
US10350288B2 (en) | 2016-09-28 | 2019-07-16 | Genocea Biosciences, Inc. | Methods and compositions for treating herpes |
CN107987159B (zh) * | 2017-11-28 | 2021-06-22 | 上海药明生物医药有限公司 | 一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法 |
CN114340665A (zh) | 2019-05-25 | 2022-04-12 | 传染病研究所 | 用于对佐剂疫苗乳剂进行喷雾干燥的组合物和方法 |
EP4058581A1 (de) | 2019-11-15 | 2022-09-21 | Infectious Disease Research Institute | Rig-i-agonist und adjuvans-formulierung zur tumorbehandlung |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1678783A (en) * | 1982-07-20 | 1984-01-26 | Molecular Genetics, Inc. | Production of herpes simplex viral proteins |
JPH085804B2 (ja) * | 1988-04-28 | 1996-01-24 | 財団法人化学及血清療法研究所 | A型及びb型肝炎混合アジュバントワクチン |
ATE179614T1 (de) * | 1990-08-02 | 1999-05-15 | Chiron Corp | Herpes simplex virus vp16 impfstoffe |
EP0563091A1 (de) | 1990-12-20 | 1993-10-06 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Impfstoffe auf basis hepatitis-b-oberflächenantigen |
JP3026029B2 (ja) * | 1991-04-26 | 2000-03-27 | 財団法人阪大微生物病研究会 | 組換え水痘ウイルスとその作製法 |
MY111880A (en) * | 1992-03-27 | 2001-02-28 | Smithkline Beecham Biologicals S A | Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a |
DE122010000016I1 (de) * | 1992-05-23 | 2010-07-08 | Glaxosmithkline Biolog Sa | Kombinierte Impfstoffe, die Hepatitis-B-Oberflächen antigen und andere Antigene enthalten |
EP0609739A1 (de) * | 1993-02-02 | 1994-08-10 | American Cyanamid Company | Methode der Umkehrung der Immunsuppression in Vakzinen |
GB9326253D0 (en) * | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
GB9409962D0 (en) * | 1994-05-18 | 1994-07-06 | Smithkline Beecham Biolog | Novel compounds |
AUPN015794A0 (en) * | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
HUP0001991A3 (en) * | 1996-02-09 | 2003-08-28 | Univ Liege | Vaccines against varicella zoster virus gene 63 product |
-
1999
- 1999-03-04 CA CA2324289A patent/CA2324289C/en not_active Expired - Fee Related
- 1999-03-04 DE DE69933200T patent/DE69933200T2/de not_active Expired - Lifetime
- 1999-03-04 TR TR2000/02608T patent/TR200002608T2/xx unknown
- 1999-03-04 CN CN99805849A patent/CN1299288A/zh active Pending
- 1999-03-04 HU HU0101047A patent/HUP0101047A3/hu unknown
- 1999-03-04 US US09/623,708 patent/US6451320B1/en not_active Expired - Lifetime
- 1999-03-04 IL IL13799899A patent/IL137998A0/xx unknown
- 1999-03-04 ES ES99914473T patent/ES2273482T3/es not_active Expired - Lifetime
- 1999-03-04 WO PCT/EP1999/001406 patent/WO1999045957A2/en active IP Right Grant
- 1999-03-04 PL PL99343429A patent/PL343429A1/xx unknown
- 1999-03-04 BR BR9908599-2A patent/BR9908599A/pt not_active IP Right Cessation
- 1999-03-04 JP JP2000535370A patent/JP4510283B2/ja not_active Expired - Fee Related
- 1999-03-04 AT AT99914473T patent/ATE339223T1/de not_active IP Right Cessation
- 1999-03-04 NZ NZ506602A patent/NZ506602A/xx unknown
- 1999-03-04 KR KR1020007009828A patent/KR20010041629A/ko not_active Application Discontinuation
- 1999-03-04 EP EP99914473A patent/EP1064025B1/de not_active Expired - Lifetime
- 1999-03-04 AU AU33283/99A patent/AU750720B2/en not_active Ceased
- 1999-03-05 MY MYPI99000825A patent/MY135965A/en unknown
- 1999-03-05 AR ARP990100970A patent/AR014684A1/es unknown
- 1999-03-09 CO CO99014298A patent/CO4960659A1/es unknown
- 1999-03-09 TW TW088103595A patent/TW580393B/zh not_active IP Right Cessation
-
2000
- 2000-09-08 NO NO20004487A patent/NO20004487L/no not_active Application Discontinuation
-
2002
- 2002-08-23 US US10/226,798 patent/US6932972B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU750720B2 (en) | 2002-07-25 |
ATE339223T1 (de) | 2006-10-15 |
IL137998A0 (en) | 2001-10-31 |
WO1999045957A2 (en) | 1999-09-16 |
NO20004487L (no) | 2000-10-19 |
BR9908599A (pt) | 2000-11-14 |
JP4510283B2 (ja) | 2010-07-21 |
NZ506602A (en) | 2003-02-28 |
TR200002608T2 (tr) | 2000-11-21 |
US6932972B2 (en) | 2005-08-23 |
AR014684A1 (es) | 2001-03-28 |
EP1064025A2 (de) | 2001-01-03 |
CO4960659A1 (es) | 2000-09-25 |
HUP0101047A1 (hu) | 2001-07-30 |
NO20004487D0 (no) | 2000-09-08 |
KR20010041629A (ko) | 2001-05-25 |
CN1299288A (zh) | 2001-06-13 |
ES2273482T3 (es) | 2007-05-01 |
US20030129199A1 (en) | 2003-07-10 |
HUP0101047A3 (en) | 2004-10-28 |
US6451320B1 (en) | 2002-09-17 |
MY135965A (en) | 2008-07-31 |
TW580393B (en) | 2004-03-21 |
WO1999045957A3 (en) | 1999-11-25 |
AU3328399A (en) | 1999-09-27 |
CA2324289C (en) | 2010-07-13 |
JP2002506045A (ja) | 2002-02-26 |
PL343429A1 (en) | 2001-08-13 |
DE69933200T2 (de) | 2007-02-22 |
CA2324289A1 (en) | 1999-09-16 |
EP1064025B1 (de) | 2006-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE339223T1 (de) | Kombinierte impfstoffzusammensetzungen | |
NO20004758D0 (no) | Vaksinesammensetning | |
ATE321569T1 (de) | Kombinierte impfstoffzusammensetzungen | |
ATE490327T1 (de) | Impfstoffzusammensetzung | |
ID26549A (id) | Komposisi-komposisi epotilon | |
ATE367793T1 (de) | Schweisshemmende zusammensetzungen | |
IS5555A (is) | Selekoxib lyfjablöndur | |
ID30031A (id) | Formulasi-formulasi agrokimia | |
ID23546A (id) | Formulasi-formulasi ziprasidon | |
DE69900634D1 (de) | Shampoozusammensetzungen | |
NO20004240L (no) | Formuleringer | |
AR023440A1 (es) | Composiciones antitranspirantes | |
ATE224703T1 (de) | Brauseformulierungen | |
IS5046A (is) | Lyfjasamsetningar | |
ATE469550T1 (de) | Antiparasitäre zusammensetzungen | |
NO20006191D0 (no) | Vaksine | |
DE69935172D1 (de) | Imidosilan Zusammensetzungen | |
ID29785A (id) | Komposisi-komposisi sampo | |
ATE257691T1 (de) | Schweisshemmende zusammensetzungen | |
ID27889A (id) | Komposisi-komposisi kopolimer polisiklik | |
IS6398A (is) | Lyfjablöndur | |
IS5694A (is) | Bóluefni | |
IS2200B (is) | Lyfjasamsetningar | |
EE200100168A (et) | Immunogeensed liposoomikompositsioonid | |
ID30320A (id) | Komposisi-komposisi berpigmen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |